← Back to All Filings

INSMED Inc Director Proposes Sale of $3.10M in Common Stock

Medium SignificanceSeptember 10, 2026 at 12:39:12 PM EDT

INSMED Inc

$INSM144CIK: 0001104506

Subscribe to track INSM

Premium users can add ticker alerts and receive realtime notification updates.

Filing Summary

Form 144 Notice of Proposed Sale of Securities Company: INSMED Inc ($INSM) Insider: David R Brennan (Director) Shares to Sell: 25,000 common shares Aggregate Market Value: $3,099,729.14 (~$123.99/share) Broker: Wells Fargo Clearing Services Approx. Sale Date: 09/09/2026

Comprehensive Analysis

Insider Filing Analysis: Form 144

Company Overview:

  • Issuer: INSMED Inc (CIK: 0001104506)
  • Exchange: Nasdaq
  • Shares Outstanding: 218,381,503

Filer Information:

  • Insider Name: David R Brennan
  • Role: Director
  • CIK: 0001609305

Transaction Overview:

  • Security: Common Stock
  • Number of Shares Proposed for Sale: 25,000
  • Aggregate Market Value: $3,099,729.14
  • Estimated Price per Share: ~$123.99
  • Approximate Date of Sale: September 9, 2026
  • Broker: Wells Fargo Clearing Services
  • Ownership Details: Shares are held via the Revocable Trust of David R Brennan, with David R Brennan serving as trustee.

Acquisition History of Shares to be Sold:

  • 6,780 shares acquired on 05/22/2024 via Equity grant from Issuer
  • 13,162 shares acquired on 05/15/2025 via Equity grant from Issuer
  • 5,058 shares acquired on 05/22/2026 via Equity grant from Issuer
Topics:#INSM#Insmed#Form144#InsiderTrading#Biotech#SEC

Get Real-Time Alerts

Join our community to receive instant notifications when high-significance filings are published

Important Disclaimer

This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.

Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.